Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice Acta Oncol
Nivolumab, Pomalidomide, and Elotuzumab Combination Regimens for Treatment of Relapsed and Refractory Multiple Myeloma: Results from the Phase 3 CheckMate 602 Study CL LYMPH MYELOM LEUK
Cyclophosphamide-free mobilisation increases safety while preserving the efficacy of autologous haematopoietic stem cell transplantation in refractory Crohn's disease patients J Crohns Colitis
Intermittent fasting as a dietary intervention with potential sexually dimorphic health benefits Nutr Rev
Late diagnosis of sitosterolemia in an adult case with unexplained hemolytic anemia Int J Lab Hematol
Genome-wide DNA methylome and transcriptome profiling reveals key genes involved in the dysregulation of adipose-stem cells in Crohn's disease J Crohns Colitis
Correction: Cryopreservation of unrelated donor hematopoietic stem cells: the right answer for transplantations during the COVID-19 pandemic? BONE MARROW TRANSPL
Total body irradiation versus thiotepa/busulfan-based conditioning regimens for myeloablative allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia BONE MARROW TRANSPL
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial JAMA-J AM MED ASSOC
Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma CANCER-AM CANCER SOC